You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Aurobindo Pharma operates in several segments including Active Pharmaceutical Ingredients (APIs), Formulations, and Biologics. It also has specialty segments like Injectables, Hepatology, and Oncology products. |
Business Models for Each Product Line |
In the API segment, Aurobindo Pharma manufactures bulk drugs sold directly to other pharmaceutical companies. The Formulations segment involves the production of finished dosage forms that are marketed to various countries across the world, generating revenue through product sales. The Biologics segment focuses on biosimilars and biologic drugs. Major expenses across these lines include raw material costs, manufacturing expenses, R&D investments, and regulatory compliance costs. |
Future Opportunities for Growth |
Aurobindo Pharma has opportunities for growth through its expansion into more complex generics and biosimilars, increasing demand for affordable medications globally, and potential expansion into new international markets such as Europe and America through strategic partnerships and acquisitions. |
Potential Major Risks |
One of the major risks includes regulatory challenges and compliance across diverse global markets. Other risks involve price erosion in generic markets, supply chain disruptions, and patent litigation issues that could impact product launches. |
Learn More about Aurobindo Pharma Ltd:
Company Insights by Algobear (ChatGPT);
Tell me more about Aurobindo Pharma Ltd's latest earnings (AUROPHARMA:Nse)
Who are some of Aurobindo Pharma Ltd's competitors? (AUROPHARMA:Nse)
Are analysts bullish on Aurobindo Pharma Ltd? Please show it in a table format. (AUROPHARMA:Nse)
Also read:
https://finance.yahoo.com/AUROPHARMA.NS/profile
| Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Quarterly Earnings Growth | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Operating Cash Flow-Display | Levered Free Cash Flow-Display | % Held by Insiders | % Held by Institutions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68047.0 Cr | 680470000000.0 | 68047.0 | 68951.0 Cr | 689510000000.0 | 68951.0 | 19.59 | 2.24 | 2.2 | 2.26 | 9.99 | 11.29% | 15.16% | 30922.0 Cr | 309220000000.0 | 30922.0 | 8.50% | 6572.0 Cr | 65720000000.0 | 6572.0 | 59.75 | -9.70% | 6868.0 Cr | 68680000000.0 | 6868.0 | 8427.0 Cr | 84270000000.0 | 8427.0 | 0.2729 | nan Cr | nan Cr | 53.82% | 27.88% |
source:https://finance.yahoo.com/AUROPHARMA.NS/key-statistics
source:https://finance.yahoo.com/AUROPHARMA.NS/key-statistics
source:https://www.google.com/finance/quote/AUROPHARMA:NSE
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|
| Upside % (high) | 8.13% | 5.05% (1278.6) | 5.05% (1278.6) | 5.05% (1278.6) | 23.47% (1502.7) | 30.8% (1592) | 30.8% (1592) | 30.8% (1592) |
| Downside % (low) | 15.36% | 7.04% (1131.4) | 17.02% (1010) | 17.02% (1010) | 17.02% (1010) | 17.02% (1010) | 67.37% (397.2) | 76.27% (288.85) |
| Spread % | -7.23% | -1.99% | -11.96% | -11.96% | 6.45% | 13.79% | -36.56% | -45.46% |
AUROPHARMA's price used for computing the stats is 1217.1 as on date
| Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|
| Last Price-Trend PrevClose | -3.24% | 7.38% | 11.25% | 4.58% | 6.06% | -16.98% | 9.21% | 72.54% | 116.59% |
| Last Price | 1217.1 | 1217.1 | 1217.1 | 1217.1 | 1217.1 | 1217.1 | 1217.1 | 1217.1 | 1217.1 |
| Trend-Previous Close | 1257.8 | 1133.4 | 1094.05 | 1163.8 | 1147.55 | 1465.95 | 1114.5 | 705.4 | 561.95 |
AUROPHARMA's symbol cumulative return percent is computed basis data from date
| 5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5D window |
5D Opportunity:
returns:
7.38%
(14.08%),
p.close: 1133.4
entry:
1293.03,
exit:
1290.12,
min.ret:
0.23%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
7.38%
(13.41%),
p.close: 1133.4
entry:
1285.39,
exit:
1311.17,
min.ret:
-2.01%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
7.38%
(11.12%),
p.close: 1133.4
entry:
1259.42,
exit:
1271.91,
min.ret:
-0.99%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
7.38%
(8.03%),
p.close: 1133.4
entry:
1224.47,
exit:
1223.79,
min.ret:
0.06%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
7.38%
(6.46%),
p.close: 1133.4
entry:
1206.64,
exit:
1207.09,
min.ret:
-0.04%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
7.38%
(6.32%),
p.close: 1133.4
entry:
1204.99,
exit:
1208.44,
min.ret:
-0.29%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2W window |
2W Opportunity:
SELL-APPROACHING
returns:
11.25%
(12.11%),
p.close: 1094.05
entry:
1226.59,
exit:
1241.13,
min.ret:
-1.19%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-APPROACHING
returns:
11.25%
(12.79%),
p.close: 1094.05
entry:
1233.94,
exit:
1236.48,
min.ret:
-0.21%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
11.25%
(9.47%),
p.close: 1094.05
entry:
1197.63,
exit:
1185.11,
min.ret:
1.05%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
11.25%
(8.16%),
p.close: 1094.05
entry:
1183.28,
exit:
1173.48,
min.ret:
0.83%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
11.25%
(8.73%),
p.close: 1094.05
entry:
1189.59,
exit:
1190.07,
min.ret:
-0.04%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1M window |
1M Opportunity:
returns:
4.58%
(14.23%),
p.close: 1163.8
entry:
1329.45,
exit:
1280.85,
min.ret:
3.66%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
4.58%
(12.03%),
p.close: 1163.8
entry:
1303.75,
exit:
1246.7,
min.ret:
4.38%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
SELL-APPROACHING
returns:
4.58%
(10.29%),
p.close: 1163.8
entry:
1283.6,
exit:
1234.44,
min.ret:
3.83%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
4.58%
(13.67%),
p.close: 1163.8
entry:
1322.88,
exit:
1320.62,
min.ret:
0.17%
Using: 1M trend, 0 Days Left
|
AUROPHARMA's symbol current price is 1217.1 (-3.24%) as on . Yesterday's close was 1257.8. It's return velocities are computed basis data from date .
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Open-High (> 1.0%) | 80.39% | 100% | 77.27% | 60.61% | 50.0% | 52.38% | 50.66% |
| Open-Low (> 1.0%) | 63.34% | 60.0% | 68.18% | 63.64% | 64.39% | 59.52% | 57.54% |
| Open-Close-Up (> 0.5%) | 55.9% | 80.0% | 40.91% | 40.91% | 32.58% | 37.3% | 34.66% |
| Open-Close-Down (> 0.5%) | 28.43% | 20.0% | 31.82% | 33.33% | 43.94% | 40.48% | 40.48% |
| Low-Close-Up (> 1.0%) | 71.14% | 80.0% | 68.18% | 65.15% | 55.3% | 59.52% | 55.03% |
| High-Close-Down (> 1.0%) | 52.62% | 40.0% | 63.64% | 59.09% | 59.09% | 54.76% | 55.82% |
AUROPHARMA's symbol win percent is computed basis data from date